Hexarelin, GHRP-2 & GHRP-6 — Doses Used in Humans and What the Evidence Shows
The real human endocrinology on GHRP-2, GHRP-6 and hexarelin: doses studied, the cortisol and prolactin problem, tachyphylaxis at sixteen weeks, and why none has a lawful compounding pathway.
The FDA Is Reconsidering Its Peptide Ban: What This Means for Your Health
A major shift in peptide regulation may be on the horizon. In late February 2026, Health Secretary Robert F. Kennedy Jr. revealed that the…
Potential FDA Peptide Reclassification 2026 – What It Means for Patients
On February 27, 2026, HHS Secretary Robert F. Kennedy Jr. announced on the Joe Rogan Experience podcast (Episode #2461) that approximately 14 of the…
